drugset / Trial / NCT01766505

The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)

NCT01766505

Phase 4 Terminated 32 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare efficacy and safety of candesartan and losartan in hypertension with heart failure.

Timeline

Start
2012-06
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Candesartan cilexetil Unknown 8 mg Oral
Subject Candesartan cilexetil Unknown 16 mg Oral
Subject Candesartan cilexetil Unknown 32 mg Oral
Comparator Losartan Other / unclassified 8 mg Oral
Comparator Losartan Other / unclassified 16 mg Oral
Comparator Losartan Other / unclassified 32 mg Oral

Indications